Investigation of Anti-CA II Antibodies in The Sera of Helicobacter Pylori Infected Patients
Abstract
It has been postulated that there may be a correlation between gastric infection caused by Helicobacter pylori (H. Pylori) and autoimmune pancreatitis (AIP). An increase in carbonic anhydrase II (CA II) autoantibodies was found in the sera of patients with AIP and it was suggested that measurement of these autoantibodies could be used in the diagnosis of AIP. In this study, the levels of CA II autoantibodies have been determined in the sera of the patients with H. pylori-infected gastritis and gastric ulcer. Anti-CA II antibody levels in the sera of these individuals were measured by ELISA method. There were significant differences between the control group and the H. pylori-infected gastric ulcer group and the gastritis group. When the H. pylori-infected and non-infected gastric ulcer and gastritis groups were compared, it became apparent that there were notable differences. The results indicated that the CA II antibodies in the sera of the H. pylori-infected patients were present at a rate of 8.3%. This led to the conclusion that CA II antibodies may not be a reliable marker for H. pylori infection. However, the investigation did demonstrate a clear increase in the levels of CA II antibodies for H. pylori-infected patients.
Keywords
References
- [1] Supuran C. T., Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection, Expert Opinion on Investigational Drugs, 33(5) (2024) 523–532.
- [2] Bayram E., Senturk M., Kufrevioglu O. I., Supuran C. T., In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II, Bioorganic & Medicinal Chemistry, 16(20) (2008) 9101–9105.
- [3] Alver A., Menteşe A., Karahan S. C., Erem C., Keha E. E., Arikan M. K., Eminağaoğlu M. S., Deger O., Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 115(5) (2007) 287–291.
- [4] Nishimori I., Onishi S., Takeuchi H., Supuran C. T., The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets, Current Pharmaceutical Design, 14(7) (2008) 622–630.
- [5] Janeway C.A., Travers P., Walport M., Immunobiology: The Immune System in Health and Disease, 5th ed. New York: Garland Science; 2001.
- [6] Nista E. C., De Lucia S. S., Manilla V., Schepis T., Pellegrino A., Ojetti V., Pignataro G., Zileri Dal Verme L., Franceschi F., Gasbarrini A., Candelli M., Autoimmune Pancreatitis: From Pathogenesis to Treatment, International Journal of Molecular Sciences, 23(20) (2022) 12667.
- [7] Inagaki Y., Jinno-Yoshida Y., Hamasaki Y., Ueki H., A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome, Journal of Dermatological Science, 2(3) (1991) 147–154.
- [8] Yokode M., Shiokawa M., Kodama Y., Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?, Diagnostics (Basel, Switzerland), 11(5) (2021) 770.
- [9] Goyal S., Sakhuja P., Autoimmune pancreatitis: Current perspectives. Indian Journal of Pathology & Microbiology, 64 (2021), S149–S159.
- [10] Aparisi L., Farre A., Gomez-Cambronero L., Martinez J., De Las Heras G., Corts J., Navarro S., Mora J., Lopez-Hoyos M., Sabater L., Ferrandez A., Bautista D., Perez-Mateo M., Mery S., Sastre J., Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis, Gut, 54(5) (2005) 703–709.